日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T cell phenotype and clonality changes in myeloma patients with short overall survival

多发性骨髓瘤患者总生存期短时,T细胞表型和克隆性发生变化

Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Slørdahl, Tobias Schmidt; Dybkær, Karen; Jakobsen, Maja Zimmer; Kashif, Muhammad; Lund, Johan; Luong, Vincent; Olsnes, Astrid Marta; Waage, Anders; Sponaas, Anne Marit; Misund, Kristine

A patient with minimal myeloma treatment who survived for 20 years

一名接受极少骨髓瘤治疗的患者存活了20年

Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Slørdahl, Tobias Schmidt; Hjorth-Hansen, Henrik; Quist-Paulsen, Petter; Misund, Kristine; Sponaas, Anne-Marit; Waage, Anders

The Prognostic Potential of circRNAs in Multiple Myeloma: Insights From Whole Bone Marrow and Purified Plasma Cells

环状RNA在多发性骨髓瘤中的预后潜力:来自全骨髓和纯化浆细胞的启示

Jakobsen, Theresa; Pløen, Gro Grunnet; Behsen, Alenka Djarmila; Møller, Holger Jon; Plesner, Torben; Dybkær, Karen; Andersen, Morten Nørgaard; Misund, Kristine; Kristensen, Lasse Sommer

Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy.

人类骨髓瘤细胞系中细胞表面标志物的异质性及其在疾病和治疗建模中的应用

Behsen Alenka Djarmila, Holien Toril, Micci Francesca, Rye Morten, Rasmussen Jenny Malm, Andersen Kristin, Hess Eli Svorkdal, Børset Magne, Keats Jonathan, Våtsveen Thea Kristin, Misund Kristine

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines

突变分析和蛋白质谱分析可预测多发性骨髓瘤细胞系的药物敏感性

Giliberto, Mariaserena; Santana, Leonardo Miranda; Holien, Toril; Misund, Kristine; Nakken, Sigve; Vodak, Daniel; Hovig, Eivind; Meza-Zepeda, Leonardo A; Coward, Eivind; Waage, Anders; Taskén, Kjetil; Skånland, Sigrid S

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

旁观者记忆T细胞与IMiD/检查点疗法在多发性骨髓瘤中的应用:一场危险的探戈?

Sponaas, Anne Marit; Waage, Anders; Vandsemb, Esten N; Misund, Kristine; Børset, Magne; Sundan, Anders; Slørdahl, Tobias Schmidt; Standal, Therese

MYC dysregulation in the progression of multiple myeloma

MYC 失调在多发性骨髓瘤进展中的作用

Misund, Kristine; Keane, Niamh; Stein, Caleb K; Asmann, Yan W; Day, Grady; Welsh, Seth; Van Wier, Scott A; Riggs, Daniel L; Ahmann, Greg; Chesi, Marta; Viswanatha, David S; Kumar, Shaji K; Dispenzieri, Angela; Gonzalez-Calle, Veronica; Kyle, Robert A; O'Dwyer, Michael; Rajkumar, S Vincent; Kortüm, K Martin; Keats, J Jonathan; Fonseca, Rafael; Stewart, A Keith; Kuehl, W Michael; Braggio, Esteban; Bergsagel, P Leif

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade

在多发性骨髓瘤中,CD39和CD73介导的ATP转化为腺苷的过程可以与腺苷受体A2A阻断剂联合使用,从而达到治疗目的。

Yang, Rui; Elsaadi, Samah; Misund, Kristine; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Moen, Siv Helen; Kusnierczyk, Anna; Slupphaug, Geir; Standal, Therese; Waage, Anders; Slørdahl, Tobias S; Rø, Torstein Baade; Rustad, Even; Sundan, Anders; Hay, Carl; Cooper, Zachary; Schuller, Alwin G; Woessner, Richard; Borodovsky, Alexandra; Menu, Eline; Børset, Magne; Sponaas, Anne Marit

Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma

克隆免疫球蛋白CDR3序列的稳定性和独特性在多发性骨髓瘤微小残留病灶追踪中的应用

Rustad, Even H; Misund, Kristine; Bernard, Elsa; Coward, Eivind; Yellapantula, Venkata D; Hultcrantz, Malin; Ho, Caleb; Kazandjian, Dickran; Korde, Neha; Mailankody, Sham; Keats, Jonathan J; Akhlaghi, Theresia; Viny, Aaron D; Mayman, David J; Carroll, Kaitlin; Patel, Minal; Famulare, Christopher A; Op Bruinink, Davine Hofste; Hutt, Kasey; Jacobsen, Austin; Huang, Ying; Miller, Jeffrey E; Maura, Francesco; Papaemmanuil, Elli; Waage, Anders; Arcila, Maria E; Landgren, Ola

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

更正:骨髓瘤细胞系中MYC扩增:与MYC抑制剂疗效的相关性

Holien, Toril; Misund, Kristine; Olsen, Oddrun Elise; Baranowska, Katarzyna Anna; Buene, Glenn; Børset, Magne; Waage, Anders; Sundan, Anders